Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):190–196. doi: 10.1097/QAI.0b013e3182167516

Figure 2.

Figure 2

Proportion of subjects in each group who had an increase in antibody level to each MsgC segment after their first AIDS-defining illness (visit 4) of ≥1.5 times the level prior to the first AIDS-defining illness (visit 3). No PcP = group that had an illness other than PcP for their first AIDS-defining illness. PcP = group that had PcP as their first AIDS-defining illness.